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Abstract
Amyloid fibrils belong to the group of ordered nanostruc-
tures that are self-assembled from a wide range of polypep-
tides/proteins. Amyloids are highly rigid structures
possessing a high mechanical strength. Although amyloids
have been implicated in the pathogenesis of several human
diseases, growing evidence indicates that amyloids may also
perform native functions in host organisms. Discovery of
such amyloids, referred to as functional amyloids, highlight
their possible use in designing novel nanostructure materials.
This review summarizes recent advances in the application
of amyloids for the development of nanomaterials and
prospective applications of such materials in nanotechnology
and biomedicine.
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P
roteins/peptides have the unique ability to self-
assemble into a variety of structures that are
capable of performing desired functions in the
biological world. For example, the biological functions of
actin filaments and microtubules depend on their self-
assembly, where they provide shape, motility and play an
important role in cell division (1). The self-assembly of
proteins could also produce unique biomaterials such as
silk, whose tensile strength is comparable to steel (2, 3).
Considerable efforts are being made in the development
of self-assembled protein/peptide based materials with
desired physical, chemical and biological applications
[For review see (4, 5)]. Recently, it has been suggested that
amyloids  a class of protein aggregates, originally
associated with human diseases (6)  could be used for
the bio-nanotechnological applications (79). In this
review, we provide an overview of amyloid fibrils and
their unique properties favorable for nanotechnology
and biotechnology applications.
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Amyloid fibrils are highly ordered protein/peptide aggre-
gates often characterized by a cross-b-sheet structure
(1012). They are associated with more than two dozen
human diseases including Alzheimer’s, Parkinson’s and
Prion diseases (6). Both natively unstructured and
structured proteins can self-assemble to these amyloid
fibrils via a partially folded intermediate (13). The
amyloid fibrils are very stable and resistant to proteases
and other harsh environmental conditions. Many recent
findings have shown the existence of functional amyloids
in nature that play a role in the host organism’s survival
rather than creating diseases (1416). Some examples
of functional amyloids include curli in E.coli, Sup35
in S.cerevisiae, and Pmel17 in mammals. Finally, many
proteins/peptides can form amyloids under certain
experimental conditions which suggests that amyloid
formation is a generic property of the polypeptide chain
(17).
Characteristics of amyloid fibrils
Amyloids possess distinct biophysical and histological
properties; (i) they are characterized by a cross-b-sheet
structure, where individual b-strands are perpendicular
and each b-sheet is parallel to the fibril axis.
The X-ray diffraction of aligned amyloid fibrils yields
two characteristic reflections at 4.7 A ˚ and 10 A ˚ ,
corresponding to the interstrand and stacking distances
between individual b-sheets, respectively (11); (ii) amy-
loids bind to histological dyes such as Congo red (CR)
(18) and Thioflavin T (ThT) (19). After binding to CR,
it produces an apple-green birefringence under cross-
polarized light. CR and ThT, however, do not bind to
monomeric proteins/peptides. These dyes fluoresce
when they bind to b-sheet-rich fibrils and are therefore
useful for spectroscopic monitoring of fibril growth and
kinetics; (iii) under the electron microscope (EM),
amyloid fibrils appear to be few micrometers long, non-
branched filaments with 612 nm diameter (Fig. 1C) (11).
In a majority of cases, amyloids are composed of 24
protofilaments that are either helically twisted or laterally
associated with each other forming higher order fibrils;
(iv) amyloids are resistant to heat, wide ranges
of pH and proteases (2022). Upon proteinase-K treat-
ments, amyloids most often produce a protease-resistant
amyloid core (23). These amyloid cores can be charac-
terized at high resolution by Hydrogen/Deuterium
(H/D) exchange experiments coupled with solution
NMR spectroscopy (23).
Mechanism of amyloid formation
Amyloid formation is not a simple two state process,
where monomeric protein/peptides simply get aggregated
into an amyloid state, rather its formation involves several
discrete intermediates before converting to mature fibrils
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‘nucleation-dependent polymerization’ process (24, 25),
where soluble native proteins are converted into aggrega-
tion-prone ‘partially folded intermediates’ that subse-
quently self-assemble into oligomers (nucleus) (Fig. 1B).
These oligomers represent a heterogeneous population of
different sized species and are highly dynamic in nature.
Oligomers further proceed into maturefibrils in avery fast
kinetics with monomer addition to the nuclei. Further,
amyloid formation can be accelerated by the addition of
‘pre-formed nuclei’ (fibrils seed), which reduces the lag
phase of nucleation (24).
Historically, amyloid fibrils are associated with
human diseases
Improper folding or misfolding of native proteins are
closely associated with disease-related amyloid formation
(6). Presently, many human diseases including Alzhei-
mer’s disease (AD), Parkinson’s disease (PD), and Type II
diabetes are associated with protein aggregation and
amyloid formation. For example, in AD, 40/42-residue
amyloid b-protein (Ab) is converted into amyloid fibrils
(26). Similarly in PD, the 140 residue a-synuclein protein
forms amyloid as intraneuronal inclusions (Lewy bodies)
(23). Amyloids can accumulate either outside the cell
(extracellular) or inside the cell (intracellular) and may be
cytotoxic. Various in vitro, in vivo and cell biological
studies have demonstrated a tight link between amyloid
formation and disease phenotypes. Recent evidences
suggest that the soluble intermediates (oligomers) are
the most plausible cytotoxic species in amyloid diseases
(2729). However, detailed structure-toxicity relationship
must be established to fully understand the nature of
toxic species responsible for the diseased condition.
Functional amyloids are widespread in nature
Recently, several studies have indicated that amyloid
fibrils are abundant in living organisms from prokaryotes
to eukaryotes, where they have evolved to perform native
functions of the host. Such amyloids are termed as
‘functional amyloids’. For example, amyloid fibrils
formed from the protein curli is used by E. coli to
colonize and bind to host surfaces (30). The amyloid
forms of Chaplins in filamentous bacterium Streptomyces
coelicolor support the organism in the development of
aerial hyphae and spore dispersal (31). The amyloid form
of yeast prions such as Sup35 and Ure2p provide selective
advantage to the host instead of causing cell death
(16, 32). Furthermore, spider silk has been reported to
show an amyloid-like cross-b-structure (33). The forma-
tion of functional amyloids has also been observed in
mammalian system. For example, Pmel17 protein, which
acts as a template for melanin polymerization, has
amyloid. At ETH Zurich, Dr. Maji made a fundamental
discovery that protein/peptide hormones could be stored
as amyloid-like structure in secretorygranules of pituitary
gland. Dr. Maji’s current research group at IIT Bombay is
involvedinunravelingthemechanismsunderlyingamyloid
formation by protein/peptides associated with human
diseases and native biological functions (functional amy-
loids). The laboratory also aims to exploit amyloid
material for drug delivery and functional bio-nanomater-
ials applications.
Fig. 1. (A) Schematic representation of amyloid aggregation. The natively folded/unfolded monomeric form of protein slowly
transforms to a partially folded intermediate and then gets converted to soluble oligomers and protoﬁbrils. These oligomers
eventually form b-sheet-rich ﬁbrils. (B) Amyloid formation by nucleation dependent polymerization mechanism showing an
initial lag phase and then elongation followed by a stationary phase. Preformed amyloid ﬁbrils can acts as a ‘seed’ to accelerate
the kinetics of ﬁbril formation by reducing the lag time. Most of the functional and disease amyloid formation follow this
mechanism. (C) Typical morphology of amyloid ﬁbrils as observed under electron microscope.
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melanosome (34). Recent studies have revealed that
peptide/protein hormones in pituitary secretory granules
are stored as amyloid-like aggregates (35). Collectively,
these results demonstrate that amyloid formation could
be physiologically useful for specific biological functions
in organisms where it is highly regulated. The unique
biophysical characteristics and discovery of multiple
functional amyloids suggest that amyloids could con-
tribute to the development of novel bio-nanomaterials.
Amyloid: a natural nanomaterial
Amyloids are highly organized fibrillar structures that
hold great potential to be used as nanomaterials
for various technological and biological applications
(Table 1). The unique properties that make amyloid fibrils
attractive for technological use include: (i) spontaneous
formation of amyloids by (m)any protein/peptides under
certain given conditions (17, 36, 37); (ii) stability, high
mechanical stiffness comparable to silk and steel (2),
and ability to form highly ordered structures (11);
(iii) nucleation-dependent polymerization process, where
preformed amyloid fibrils can act as seed to accelerate
the kinetics of fibril formation (24); (iv) ability to tune
physico-chemical properties of amyloid by modulation of
amino acid sequences (38); (v) ease of functionalization
of individual fibrils for specific applications (39). The
functional group may be recruited at the amino acid
side chain for applications such as receptor-ligand and
gold-thiol interactions (8, 39); (vi) higher order amyloid
aggregation of fibrils leading to formation of complex
networks of filaments, gels and films (38, 4042) that may
be suitable for immobilizing enzymes, small molecules and
drugs. Apart from these above-mentioned properties,
amyloids display structural plasticity and their formation
could be reversible depending upon the condition.
Amyloids: highly stable and comparable to steel
Amyloid fibrils possess robust mechanical properties,
which highlights their possible applications in nanotech-
nology. Smith and coworkers characterized the mechan-
ical properties of individual insulin amyloid fibrils using
atomic force microscopy and spectroscopy. Their data
revealed that amyloid fibril possess mechanical strength
(0.6 90.4 GPa) comparable to that of steel (0.61.8 GPa)
and silk (11.5 GPa) (2). To determine the molecular
forces responsible for the stability of different amyloid
fibrils, Knowles et al. performed AFM topographical
studies with individual amyloid fibrils formed by a- and
b- lactalbumin, insulin, and transthyretin 105115 (3).
Intriguingly, the bending rigidity (CB) of these fibrils
varied about four orders of magnitude. The data further
suggests that stiffness of individual amyloids is deter-
mined by the extent of intermolecular interactions
between peptide backbones and is indicative of the
common mechanism underlying the mechanical proper-
ties of these supramolecular structures. Furthermore,
comparison of material properties of amyloid fibrils
with other classes of materials of biological origin (for
example, tubulin, capture silk and elastin) revealed that
amyloid fibrils are stiffer than most intracellular biolo-
gical filaments (3). Simulations aimed at calculating the
elastic constants as a function of the size of amyloid
fibril of Ab40 demonstrated that the length of amyloid
fibrils significantly influenced their stability, with the long
fibrils found to be more stable and mechanically rigid
compared to the shorter ones (43). The self-assembled
peptide fibrils are stable over a wide range of pH, salt
concentrations (21), pressure (up to 1.3 GPa) (44) and
are also resistant to proteolysis and dehydration. The
amyloids fibrils were also found to be stable up to 1008C
temperature (20). The extensive hydrogen bond network
and side-chain interactions in steric-zipper of tightly
Table 1. Amyloids and their potential applications in bio-nanotechnology
Amyloid Application(s) Reference
Amyloid peptide (105115) of transthyretin protein Functionalized amyloid fibrils for cell adhesion (8)
Amyloid of Gonadotropin releasing hormone (GnRH) analogs Depot-formulation of long acting peptide/protein
drugs
(38)
Self-assembling decapeptide (killer peptide, KP) from Candida
albicans
Model for auto-delivering therapeutic peptides (78)
a-synuclein fibrils Amyloid hydrogel for enzyme entrapment (41)
Sup35p NM domain (Yeast) Development of nanowires (39)
Bovine insulin fibrils (integrated with semi-conducting
oligoelectrolytes)
Nanowire for optoelectronic application (89)
Insulin fibrils (coated with polymer PPF) Use of amyloid fibrils in polymer light emitting diodes (90)
Insulin fibrils (coated with conjugated polymer APFO-12) Nanowires for optical applications (91)
Insulin fibrils (coated with PEDOT-S) Conducting nanowire development (92)
Hen egg white lysozyme amyloid fibrils Development of thin films (42)
b2-microglobulin Development of nanoporous matrix (82)
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extraordinary stability (45).
Structural and morphological plasticity of amyloid
fibrils
The distinct features of amyloid fibrils including size,
shape, morphology, and secondary structure could be
modulated by varying experimental conditions (such as
pH, agitation, temperature, salt concentration etc.) that
are employed for the formation of amyloids from its
monomeric peptide/protein counterpart. Amyloid-like
fibrils have been seen in a range of different shapes and
forms including curly twisted fibrils, linear straight fibrils,
rods, tapes and spherical clusters (such as spherulites)
(40, 4649). Tycko and coworkers have shown that two
different modes of aggregation of Ab40 lead to morpho-
logically distinct amyloids with different secondary
structure and toxicity (50). Recently, studies on the
structure and intermolecular dynamics of amyloid fibrils
by H/D exchange experiment revealed that monomers
of amyloid fibrils are in continuous recycling within the
fibrils (51). Amyloid fibrils assembly could also be
reversed by changing conditions such as pH and dilution
(20, 35, 38, 52). The recycling behavior of amyloid fibrils
may be exploited for specific applications. For example,
the property of reversible self-assembly has been utilized
in formulating long-acting drugs where controlled release
of peptide molecule occurs from the fibril termini (38).
Furthermore, the reversibility and structural plasticity
could play important role in modulating the degradability
of amyloid fibrils.
Amyloid technology
Developing novel and biocompatible scaffolds for appli-
cations in drug delivery, tissue repair/engineering and
other nanotechnological devices is one of the key areas
in modern science. Significant attempts have been made
using bottom up approach with peptide/protein self-
assembly to create functional biomaterials for applica-
tions ranging from biotechnology to nanoelectronics. The
physico-chemical and mechanical properties of amyloids
could be tailored either by modulating amino acid
sequence of constituting peptides/proteins or using dif-
ferent experimental parameters such as pH, temperature
and pressure (20, 21, 44). Recent advances in computer
algorithms/tools that can determine the secondary struc-
ture, hydrophobicity and/or aggregation propensity of the
protein have made it possible to design amyloid-based
materials with desired properties.
Amyloids fibrils as a bioactive matrix for tissue
engineering
Development of biocompatible nano-scaffolds provi-
ding suitable microenvironment for cell survival in vivo
holds immense scope in cell-based therapies. Several
biocompatible materials and natural polymers have
already shown great promise in this area (53). Peptide/
protein self-assembly could also produce diverse set of
biomaterials mimicking the extracellular matrix that
can promote cell adhesion, migration and differentiation
(5456). Zhang and co-workers developed novel self-
complementary b-sheet peptides using alternative positive
and negative L-amino acids that could self-assemble
under physiological conditions and form hydrogels (57
59). These peptide fibrils were able to form extensive
networks and support neuronal cell attachments, differ-
entiation and extensive neurite outgrowth (60). Moreover,
the scaffolds made by self-assembling peptides functiona-
lized with different motifs (e.g. osteogenic growth peptide
ALK in osteoblast tissue culture) served as excellent
material for three-dimensional cell culture systems (61,
62). The peptide scaffolds promoted proliferation and
osteogenic differentiation of mouse MC3T3-E1 cell,
suggesting its application in bone tissue engineering (62).
In addition, these materialswere useful invascularization,
where it created a cellular milieu within the myocardium
for survival and organization of endothelial cells
(63). It was also reported that self-assembling peptide
KLD-12 hydrogel provides an excellent scaffold for the
production and accumulation of a cartilage-like ECM
within 3D tissue culture that have application in cartilage
tissue repair (55).
Amyloid fibrils can similarly be utilized for the devel-
opment of scaffolds for tissue engineering applications
(Fig. 2A). Amyloid fibrils made from peptide/proteins
with or without tagged functional moieties and/or fibrils
immobilized with functional protein/peptides (such as
laminin or fibronectin) can be used as scaffolds for
promoting cell attachment and growth (8). Recently,
Gras and co-workers (2008) reported that amyloid fibrils
made from the partial amino acid sequence of the
transthyretin containing the RGD ligands (adhesion
moieties) on the fibril surface provide accessibility for
cell adhesion. The design of such functionalized fibrils
can be exploited to promote interactions with a wide
variety of cell types (8). Amyloid fibrils can also be used
in enamel repair via bioactive surface groups and hard
tissue engineering as proteins from demineralized enamel
matrices form filaments with cross-b sheet like structure
(64, 65).
Possible applications of amyloids as scaffolds for
controlling stem cell fate
Stem cells are defined by their ability to self-renew and
differentiate into different types of specialized cells. As a
consequence, they represent the most versatile cell source
for the regeneration of aged, injured, or diseased cells.
However, the major roadblock in using stem cell thera-
pies is due to difficulties in maintaining stem cells in their
self-renewing state under ex vivo conditions. In vivo, stem
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termed as the stem cell niche. This has led to the
hypothesis that mimicking the stem cell niche will lead
to better control of stem cell self-renewal and differentia-
tion ex vivo. The stem cell niche comprises of stem cells,
niche cells, growth factors and the extracellular matrix
(ECM). Of these, the ECM provides structural support to
the cells therebyregulating cell division, cell adhesion, and
cell migration. In addition, the ECM also presents
biochemical signals to cells in a spatio-temporal manner.
Taken together, robust control of stem cell fate requires a
precise tuning of each of these factors, both spatial and
temporal.
The stem cell niche is very complex to reproduce.
Nonetheless, a major emphasis in the field of tissue
engineering is to develop natural and synthetic substrates
as suitable stem-cell microenvironments for controlling
stem cell fate. A lot of these efforts are focused on
identifying and understanding the role of the physical
and biochemical features of the ECM in modulating stem
cell fate. Of these, ECM stiffness and ECM topography
have emerged as two key parameters regulating cell
function in normal and diseased tissues in a range of
different cell types, including stem cells.
Usingapolyacrylamide-basedhydrogelsystem,Discher
and co-workers (66) demonstrated that human mesench-
ymal stem cells (MSCs) are exquisitely sensitive to ECM
stiffness. Intriguingly, MSCs presented with an ECM of a
defined rigidity differentiate towards the cell/tissue type
whose in vivo stiffness most closely matches that of the
ECM. Thus, MSCs became neuron-like on soft gels,
myoblast-like on substrates of intermediate stiffness, and
osteoblast-like on the stiffest gels. In a separate study,
adult neural stem cells cultured on hydrogels of varying
stiffness gave rise to glial cells on stiff substrates but
became neuronal on soft substrates (67). In order to
translate these findings to an in vivo setup, one needs to
develop natural and biocompatible hydrogels, which can
encapsulate the stem cells, maintain their survival and
provide the necessary physical and biochemical signals
for differentiation.
Fig. 2A. Amyloid as a scaffold for tissue engineering. (A) The ﬁgure represents amyloid scaffold utilization for neuronal cell
attachment, neurite outgrowth and synapse formation.
Fig. 2B. Amyloid as a scaffold for tissue engineering. (B) Stem cells may adhere to natural amyloid hydrogels directly, or to
those functionalized with different cell adhesion moieties (e.g. RGD). Varying the ﬁber stiffness or alignment can be tuned to
direct stem cell differentiation into different lineages. Furthermore, amyloid hydrogels could be designed with immobilized
ligands or entrapped growth factors within, with the action or release kinetics of which tuned to obtain desired stem cell
response/behavior.
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phies depending on the type of ECM composition.
Collagen, the most abundant ECM protein organizes
into 3-dimensional fibrils, and plays a significant role in
tissue organization by directly modulating cell shape. The
success in using electrospun nanofibers as scaffolds for
culturing stem cells can be attributed to their morpholo-
gical resemblance with ECM fibers. Such scaffolds have
been successfully employed in achieving chondrogenic,
osteogenic andadipogenic differentiationof MSCs in vitro
(68), several fold expansion of neural and embryonic stem
cells (ESCs) in vitro compared to tissue culture plastic
surfaces (69, 70), and in the in vivo repair of articular
cartilage defect using MSCs (71).
The ability to tune the microstructure and mechanical
strength of amyloid fibrils, ease of attaching any cell
adhesion moiety, and the ability to control ligand density
on the fibrils, we hypothesize that amyloid-based hydro-
gels may be an attractive platform for growing and
maintaining stem cells in vitro, directing stem cell differ-
entiation, as well as using these hydrogels for implanting
stem cells in vivo (Fig. 2B). For example, while the steel-
like stiffness of these fibrils may be ideally suited for
differentiating stem cells into osteoblasts, the high degree
of order in amyloid fibrils provide a topographic cue
for stem cells to differentiate into neurons. However,
it is not a priori clear what the stem cells will differentiate
into when presented with both the cues simultaneously.
Moreover, a new class of fibrils must be developed
whose stiffness can be tuned over a wide range for
stem cell differentiation, or for maintaining ESC self-
renewal where soft substrates are required (72).
Modulation of fibril diameter, fibril alignment, and
engineering nanotopographyon amyloid fibrils represents
another exciting avenue to pursue (Fig. 2B). While fibril
diameter will directly influence cell adhesion area, fibril
alignment can be particularly suited for differentiating
stem cells into skeletal muscle cells, articular cartilage and
blood vessels. Moreover, nanotopographic cues can be
superimposed on fibrils to further aid in controlling stem
cell fate. For example, presence of 350 nm nanogratings
was found to be sufficient to induce neuronal differentia-
tion without addition of retinoic acid (73).
Finally, biophysical cues can be combined with chemi-
cal cues for regulating stem cell fate using amyloid-based
materials. In addition to controlling fibril stiffness, size
and roughness, growth factors and cytokines like fibro-
blast growth factor 2 (FGF2) and leukemia inhibitory
factor (LIF) can be entrapped within the fibril network
and their release kinetics can be further tuned to have
an additional handle towards fine tuning stem cell
response and obtaining the desired behavior. Taken
together, precise control of stem cell fate requires the
presence of multiple factors in the right arrangement and
orientation within a well defined scaffold of defined
stiffness and topography together with specified bio-
chemical gradients, and amyloid-based hydrogels can
potentially serve as good stem cell culture systems.
Amyloids as a novel depot formulation in drug
delivery
The protein/peptide drugs often require special means of
delivery such as infusion and subcutaneous administra-
tion to prevent them from protease degradation (74, 75).
Various formulations of peptide/protein drugs have been
developed, which aid in achieving controlled release of
drugs over an extended period of time thus maintaining
a uniform drug concentration. Administration of self-
assembled peptide/protein drugs represents one of the
effective modes of drug delivery. For example, it was
shown that crystallization of insulin and TGF-b3p r o -
vides sustained release mechanism, where micro-crystals
can serve as a protected reservoir of releasing active drugs
(76, 77). Similarly, recent studies have suggested that self-
assembly of protein/peptides into amyloid conformation
could be used in drug delivery either as drug delivery
vehicles or as drugs themselves (38) (Fig. 3). It was
suggested that long-acting gonadotrophin releasing hor-
mone (GnRH) analogs are able to form amyloids in vitro,
which can sustain the release of monomeric drugs in vitro
and in vivo. In contrast, most of the short acting analogs
either remain monomeric in solution or form amyloids
with high stability (with slow release capability). Addi-
tionally, some short acting analogs formed amyloid with
very low stability that release monomer instantaneously.
The short-acting analogs, which are not able to form
amyloids in vitro, might form amyloids when incubated
for extended periods and showed activity over long
durations in vivo (38). This study clearly demonstrated
that amyloid form could work as a reservoir of drugs.
Moreover, the amyloid termini can release the active
peptide drug in a controlled manner over a period of
several weeks. The advantages of designing amyloid as a
depot formulation is that it will maintain convenience,
drug dosage within desired range, and patient compli-
ance. The only concern is that amyloids have to be
non-toxic and should be able to release the functional
monomers. Also, it should not cross-react with other
disease related amyloid forming proteins or act as a seed
for disease-progression (38). The property of reversible
self-assembly of peptides into fibrils encourages a new
model of auto-delivering therapeutic peptides as exhib-
ited by a therapeutic antibody-derived decapeptide (killer
peptide, KP) from Candida albicans (78). The controlled
release profile obtained with oligomers made from insulin
at pH 7.0 further highlights the potential of using
oligomers formulations for long-acting protein/peptide
drugs (79).
The self-assembling peptide/protein nanofibrils may
also serve as excellent drug carriers. Zhang and
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system of RADA16 hydrogels could serve as a slow
delivery carrier of various small molecules as well as
variety of proteins such as lysozyme, trypsin inhibitor,
bovine serum albumin (BSA) and immunoglobulin G
(IgG) (80, 81). Similarly, supramolecular networks of
amyloids can entrap small molecules, drugs, protein/
peptides and enzymes where it could work as a vehicle
for drug delivery. The drug molecules will be protected
from heat, enzyme degradation, as they are entrapped in
the stable core of the cross-b-sheet-rich structure. Recent
work suggests that hydrogels formed from curly-amyloid
fibrils ofa-synuclein canserveasananomatrix forenzyme
entrapment (41). Further, their capacity to sustain enzyme
activity and act as resistance barrier against the heat
treatment highlight their potential to be used in therapeu-
tic delivery (41). Amyloid fibrils of b2-microglobulin
(associated with dialysis-related amyloidosis) were re-
cently utilized to construct nanoporous protein matrix
with high mechanical strength and may be used in drug
delivery and tissue engineering applications (82).
Development of metal nanowires and biosensors
using amyloids
Self-assemblyof amyloidogenic peptides into fibril nanos-
tructures can play an important role in building nanowires
and nanoelectronic materials. For example, nanotubes
made by the self-assembly of Phe-Phe dipeptide from
the central region of amyloid b-peptide (Ab, associated
with Alzheimer’s disease) was successfully utilized as
a template for metal nanowire formation (Fig. 4A) (4,
8386). The obvious advantages of such dipeptide-based
nanotubes are their ease of synthesis and biodegradabi-
lity. These peptide nanotubes could be produced in large
scale without significant cost, and their degradation could
be further modified using D-amino acids. Phe-Phe nano-
tubes can be formed by vapor deposition method and
can self-assemble in aqueous solution (87). Therefore,
using these kinds of dipeptide templates and their strong
tendency to self-associate, it is easy to construct various
functional nanomaterials. The amyloid forming capabil-
ities of NM domain of the yeast Sup35p was successfully
used for constructing metal nanowires that were able
to conduct electricity with low resistance (39). In this
study, the genetically engineered cysteine mutant of NM
was fibrillized, where surface accessible cysteine was
covalently linked to monomaleimido nano-gold. These
nano-gold bound NM fibrils were used as promoters for
reducing silver ions from the solution and the resulting
silver coated fibrils were further used to deposit gold for
making metal nanowires (Fig. 4B).
Enhancement of desired properties of conducting
materials can also be achieved using peptide nanotubes
and fibrils. For example, Yemini et al. reported that the
electrochemical properties of graphite and gold electrodes
could be improved with the help of peptide nanotubes,
Fig. 3. Schematic representation of the application of amyloid for drug delivery. Protein/peptides drugs under appropriate
conditions can form amyloid ﬁbrils. These ﬁbrils could release functional protein/peptides from the ﬁbril termini after
administration, allowing a controlled release of monomeric drug (top) (38). Nontoxic protein/peptide oligomers (blue spheres)
may similarly be used for auto-delivery of the drugs (middle) as suggested for insulin (79). The monomeric drug released in both
the above cases could perform their action at the targeted site. Amyloids also might be utilized as a vehicle for drug delivery,
wherein the drug molecules (orange spheres) could be entrapped within amyloid networks (violet mesh) ensuring the slow
release of the drugs after administration. The ﬁgure shows the drug release occurs at the target site and binds to speciﬁc
receptors on the cell surface to perform its action (bottom).
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This technique could be useful for the development of
(bio)sensors with high analytical performances. Integrat-
ing amyloid fibers and polymers can lead to novel
nanocomposite materials with high performance of
material properties. Herland et al. integrated semi-con-
ducting conjugated oligoelectrolytes with bovine insulin
where both components co-assembled to form electro-
active luminescent fibrillar nanowires (89). It is also
important to note that the organization/orientation of the
polymers within the amyloid fibrils may influence various
material properties (e.g. optoelectronic property in the
above study). Amyloid nanofibrils of insulin, when
decorated with luminescent polymer PPF resulted in a
complex that could successfully be employed as an active
layer in light emitting diode (LED) (90). The external
quantum efficiency of PPF and PPF-coated amyloid-
complex were compared, and it was found that the
quantum efficiency of the former was  0.01% (current
density range: 1100 mA/cm
2), whereas that of the latter
device was more than 0.1% (current density range: 0.01
20 mA/cm
2). The PPF-insulin fibrils complex thus
exhibited a ten-fold increase in the external quantum
efficiency when compared to pure PPF alone (90).
Furthermore, when insulin amyloids were coated with a
polar, non-charged conjugated polymer APFO-12, the
polymer chains were found to align along the fibrils with
varying degrees of polarization. The increased anisotro-
pic behavior of the polymer along the fibrils could be
utilized for the development of nanowires for optical
applications (91). Hamedi et al. demonstrated that
conjugated polymer alkoxysulphonate PEDOT could be
coated onto insulin amyloid fibrils through self-assembly
producing electrically active networks of conducting
nanowires (92) (Fig. 4C).
Amyloid can also be utilized for protein immobiliza-
tion and biosensor development. For example, amyloid
surface can be functionalized with ligands such as
fluorophores, cytochromes, enzymes and other tags
according to the desired application in nanotechnology
(8, 9, 9395). The enzymatic properties and stability of
enzymes can be improved by immobilizing them on the
surface of amyloid nanofibrils (96). In this aspect, it was
reported that organophosphate hydrolase (OPH), when
covalently immobilized on bovine insulin fibrils using
glutaraldehyde as a cross-linker, resulted in significant
increase in the thermal stability of the enzyme compared
to the free enzyme (96). Similarly, antibodies could be
immobilized on the amyloids for detecting specific
antigens.
Other potential applications of amyloid
nanofibrils
Recently, Knowles et al. prepared rigid nanostructure
thin films from hen egg white lysozyme and bovine
b-lactoglobulin amyloid fibrils. These self-assembled
macroscopic films can align the unstructured fluoro-
phores within the macroscopic films (42) reflecting the
Fig. 4. Nanowire development using self-assembling peptide/proteins and amyloid ﬁbrils. (A) The nanotubes made by the self-
assembly of Phe-Phe dipeptide were utilized as a template to form silver nanowires (83). (B) Cysteine labeled amyloid was used
to develop metal nanowires, by ﬁrst covalently linking the nano-gold to surface exposed Cys residues, followed by silver ion
reduction in solution to provide a silver coating, and subsequently making deposition of gold (39). (C) Insulin amyloid ﬁbrils
coated with alkoxysulphonate PEDOT-S was able to generate conducting nanowires (92).
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Nanoscale characterization of amyloid fibrils in natural
adhesives of algae by Mostaert et al. revealed the generic
mechanism of mechanical strength of the adhesives (97).
These bio-adhesives with increased mechanical strength
and stability might be useful for application in coating
industries. Other prospective applications of amyloid
fibrils could be in food industry and in the development
of nanofilters and bioseparators.
Conclusions and future directions
Generation of novel biomaterials with diverse structure
and functions is one of the upcoming fields in biotechnol-
ogy. Organic polymers as well as biopolymers have
long been exploited to devise biomaterials for various
nano- and bio-technological applications including nano-
wires/nanotubes development, regenerative medicine and
drug delivery (53, 98101). Engineering nanoscale devices
using protein/peptide self-assembly is especially important
in this regard as it could adapt lessons from nature
that produced numerous biomaterials. In this review, we
highlight the various applications of amyloids in nano-
biotechnology. Although most of the attention on amy-
loids has been channeled into studying their role in several
human diseases, a paradigm shift in the understanding of
amyloid biology has evolved in the last few decades,
suggesting the vast potential of amyloid to perform as an
elegant biomaterial. The de novo design of amyloids and
the ability to modify their physicochemical properties,
alongwiththedevelopmentofcomputerbasedalgorithms
[such as TANGO (102)], has made it possible to utilize
the versatile properties of amyloids for developing several
new classes of biomaterials.
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